Sign in

CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
  1. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change · Other events
  2. 8-A12B Other Registration of Securities
  3. 10-K Report Annual Report
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. 4 Open-market sale 10% owner sold 3,700,000 shares at an average $0.83 ($3,056,000)
  11. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change
  12. 8-K Event Delisting notice · Regulation FD disclosure
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Regulation FD disclosure · Other events
  15. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure · Other events
  16. 4 Grant or award See Remarks acquired 3,000 shares (grant or award)
  17. 4 Grant or award See Remarks acquired 3,000 shares (grant or award)
  18. 4 Grant or award Chief Commercial Officer acquired 3,000 shares (grant or award)
  19. 4 Grant or award See Remarks acquired 3,000 shares (grant or award)
  20. 4 Grant or award Chief People Officer acquired 3,000 shares (grant or award)

Page 16 of 33 · 660 filings